Description
METHOCARBAMOL, TIZANIDINE, ATORVASTATIN CALCIUM
First action · last action
2018-08-30 · 2018-10-25
Transactions
4
First transaction's obligation
$18,051
Base + all options value (sum of deltas)
$10,583
Extent competed
FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES
Other than full & open authority
—
Set-aside
SERVICE DISABLED VETERAN OWNED SMALL BUSINESS SET-ASIDE
Offers received
7
SDVOSB flag on record
Yes (self-representation)
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 4 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2018-08-30+$18,051= $18,051
- Mod P000012018-09-13-$7,468= $10,583
- Mod P000022018-10-01+$0= $10,583
- Mod P000032018-10-25+$0= $10,583
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2018-08-30 | +$18,051 | $18,051 | METHOCARBAMOL, TIZANIDINE, ATORVASTATIN CALCIUM |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2018-09-13 | −$7,468 | $10,583 | METHOCARBAMOL, TIZANIDINE, ATORVASTATIN CALCIUM |
| Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2018-10-01 | +$0 | $10,583 | METHOCARBAMOL, TIZANIDINE, ATORVASTATIN CALCIUM |
| Mod P00003· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2018-10-25 | +$0 | $10,583 | METHOCARBAMOL, TIZANIDINE, ATORVASTATIN CALCIUM |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI ZF9NMTKAM3W6)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C77022P0349 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $14,976 | FY2022 |
| 36C77022P0028 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $5,399 | FY2022 |
| 36C77022P0022 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $9,250 | FY2022 |
| 36C77021P0524 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $12,503 | FY2021 |
| 36F79720D0114 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $0 | FY2020 |
| 36C77020P0424 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $88,088 | FY2020 |
Other recipients under 6505 from NATIONAL CMOP OFFICE (36C770) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C77026P0118 | HYGEN PHARMACEUTICALS INC | NATIONAL CMOP OFFICE (36C770) | $30,935 | FY2026 |
| 36C77026P0129 | DERRAH MORRISON ENTERPRISES LLC | NATIONAL CMOP OFFICE (36C770) | $76,656 | FY2026 |
| 36C77026P0127 | DERRAH MORRISON ENTERPRISES LLC | NATIONAL CMOP OFFICE (36C770) | $58,395 | FY2026 |
| 36C77026P0086 | SAGENT PHARMACEUTICALS, INC | NATIONAL CMOP OFFICE (36C770) | $275,580 | FY2026 |
| 36C77026P0095 | HYGEN PHARMACEUTICALS INC | NATIONAL CMOP OFFICE (36C770) | $83,520 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C77018P1694_3600_-NONE-_-NONE- · retrieved 2026-09-26.